Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Allergy Thera. (AGY) Share Price

Price 8.00p on 07-10-2025 at 18:40:05
Change -0.30p -3.61%
Buy 8.50p
Sell 7.50p
Last Trade: Unknown 20,000.00 at 8.00p
Day's Volume: 356,296
Last Close: 8.00p
Open: 8.45p
ISIN: GB00B02LCQ05
Day's Range 8.00p - 8.45p
52wk Range: 4.25p - 9.00p
Market Capitalisation: £381.32m
VWAP: 7.99798p
Shares in Issue: 4.77b

Allergy Thera. (AGY) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 20,000 8.00p Ordinary
16:38:09 - 07-Oct-25
Unknown* 16,000 8.00p Uncrossing Trade
16:35:15 - 07-Oct-25
Sell* 1,107 7.85p Ordinary
15:23:43 - 07-Oct-25
Buy* 1 8.15p Ordinary
14:36:34 - 07-Oct-25
Sell* 13,576 7.85p Ordinary
14:08:21 - 07-Oct-25
Unknown* 10,000 8.00p Ordinary
13:56:50 - 07-Oct-25
Sell* 12,739 7.85p Ordinary
13:08:04 - 07-Oct-25
Unknown* 625 8.00p Ordinary
09:19:42 - 07-Oct-25
Unknown* 5,000 8.00p Ordinary
09:06:44 - 07-Oct-25
Unknown* 109 8.00p Ordinary
09:03:53 - 07-Oct-25
See more Allergy Thera. trades

Allergy Thera. (AGY) Share Price History

Time period:
to
Date Open High Low Close Volume
7th Oct 2025 (Tue) 8.45 8.45 8.00 8.00 356,296
6th Oct 2025 (Mon) 8.70 8.70 8.00 8.30 316,498
3rd Oct 2025 (Fri) 8.50 8.50 8.00 8.50 363,632
2nd Oct 2025 (Thu) 8.50 8.50 8.00 8.50 97,333
1st Oct 2025 (Wed) 8.50 8.50 8.00 8.45 121,620
30th Sep 2025 (Tue) 8.45 8.45 8.00 8.45 77,763
29th Sep 2025 (Mon) 8.40 8.45 8.00 8.45 65,421
26th Sep 2025 (Fri) 8.30 8.30 8.00 8.30 301,561
25th Sep 2025 (Thu) 8.30 8.30 8.00 8.30 141,738
24th Sep 2025 (Wed) 8.30 8.30 8.00 8.30 46,698
23rd Sep 2025 (Tue) 8.30 8.30 8.00 8.30 33,500
22nd Sep 2025 (Mon) 8.30 8.30 8.00 8.30 119,036
19th Sep 2025 (Fri) 8.30 8.30 8.00 8.30 51,600
18th Sep 2025 (Thu) 8.20 8.30 7.90 8.30 166,751
17th Sep 2025 (Wed) 8.30 8.30 8.20 8.20 254,104
16th Sep 2025 (Tue) 8.00 8.30 8.00 8.30 373,247
15th Sep 2025 (Mon) 8.30 8.30 8.00 8.30 381,253
12th Sep 2025 (Fri) 8.50 8.50 7.75 8.30 635,925
11th Sep 2025 (Thu) 8.20 8.50 8.00 8.30 19,254
10th Sep 2025 (Wed) 8.00 8.00 7.75 8.00 479,093
9th Sep 2025 (Tue) 8.15 8.15 7.50 8.10 389,219
8th Sep 2025 (Mon) 8.00 8.50 8.00 8.35 66,412
See more Allergy Thera. price history

Allergy Thera. (AGY) Share News

Allergy Therapeutics shares slump as expects to post revenue decline

21st Jul 2025 13:47

(Alliance News) - Allergy Therapeutics PLC on Monday said it expects to report a small decline in earnings during its most recent financial year, as a result of regulatory changes within its key German market. Read More

LONDON MARKET OPEN: London stocks climb as miners and gold shine

21st Jul 2025 08:58

(Alliance News) - European equities were muted at the market open on Monday, beaten by the FTSE 100 as the index passed the 9,000 mark on a boost from miners. Read More

Allergy Therapeutics half-year loss narrows on lower expenses

31st Mar 2025 12:24

(Alliance News) - Allergy Therapeutics PLC on Monday said talks are underway regarding further financing as it said reduced costs helped trim its half-year loss. Read More

Allergy Therapeutics peanut allergy vaccine trial enters final phase

27th Mar 2025 18:27

(Alliance News) - Allergy Therapeutics PLC on Thursday said its peanut allergy vaccine trial has entered the final treatment phase. Read More

IN BRIEF: Allergy Therapeutics expects annual sales to rise on-year

28th Jan 2025 21:19

Allergy Therapeutics PLC - Sussex, England-based biotechnology company - Expects revenue to rise by 1.1%, or by 4% at constant currency, to GBP34.0 million in the six months ended December from GBP33.6 million a year ago. Sales are expected to continue to grow in the second half of the financial year. Overall, expects sales for the full year ending June 30 to exceed sales in the corresponding period ended June 2024. Reports cash position of GBP21.7 million at the end of December, rising from GBP12.9 million a year ago, following receipt of new GBP20 million five-year term loan. Chief Executive Manuel Llobet says: "We enter 2025 building strong momentum across all aspects of our business. Our return to first-half growth and strengthened position, having secured the Hayfin facility in late 2024, give us the confidence and financial stability to further our ambitious strategy." Read More

See more Allergy Thera. news
FTSE 100 Latest
Value9,483.58
Change4.44

Login to your account

Forgot Password?

Not Registered